Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

https://t.co/uBZbvVYoxY

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison https://t.co/D7K80bmlxf

@kallmemeg @BristOliver ONS: https://t.co/7VzSqy1LL0 Assay assessment: https://t.co/rJcodviodw

RT @JohannHolzmann: https://t.co/B4gqM93oIo https://t.co/4U8nr2TpAx https://t.co/l3JcSYWXuJ https://t.co/Eg5hjWRLYf

https://t.co/B4gqM93oIo https://t.co/4U8nr2TpAx https://t.co/l3JcSYWXuJ https://t.co/Eg5hjWRLYf

RT @JohannHolzmann: https://t.co/l3JcSYWXuJ Ergebnisse können verglichen werden, wenn im Analysenergebnis steht, dass der Test auf den WHO…

https://t.co/l3JcSYWXuJ Ergebnisse können verglichen werden, wenn im Analysenergebnis steht, dass der Test auf den WHO Standard normalisiert ist.

Some of our work contributes to the ongoing sero-surveillance data in the weekly reports (https://t.co/6NM8LHzrGJ), but also research projects such as... Head-Head: https://t.co/dV2a2wJKbx Antibody responses post dose 1 in naive/prev infection: https:/…

@pawlak_MD Nie ma wyniku większego niż 300. Wykres pochodzi z artykułu opublikowanego w Lancet. https://t.co/MuNSP6Q9DA 3/3

https://t.co/bMXYe9lGro https://t.co/nZlYr0ihUX

X https://t.co/4viALcRHcW

https://t.co/mvc263YAWa

2/ רפרנסים: מאמר - https://t.co/JOoLcp0cB5 רכש נוגדנים של משרד הבריאות - https://t.co/G6boUr2Mc7

Sars 2 Science https://t.co/4viALcRHcW

https://t.co/IdLNLTIkj1 https://t.co/aZyxepiqN0

@elonmusk @RationalEtienne @ryaneshea This immunoassay performance study compares 5 of the covid tests. https://t.co/KjOvw0l0RS

@elonmusk See here: https://t.co/KjOvw0l0RS

Sars https://t.co/4viALcRHcW

@Nadav_Eyal מאיפה הנתון? המערכות הללו די מדוייקות https://t.co/H6MgQYgzpc https://t.co/Mkvpf5qRo1

Siemens mach die besten Corona Schnelltests - Abbott die schlechtesten. Abbott wurde im Weißen Haus benutzt.

RT @UNMC_DrKhan: Head to head comparison of 5 immunoassays for #COVID19 antibodies. Chock full of good epi lessons like role of cutoff is d…

Head to head comparison of 5 immunoassays for #COVID19 antibodies. Chock full of good epi lessons like role of cutoff is determining the sensitivity and specificity. Good choice after 15+ days. https://t.co/E39AB48C3F https://t.co/8xjfyi5u6G

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

RT @jmayer0716: Performance characteristics of five immunoassays for #SARS-CoV-2: a head-to-head benchmark comparison - The Lancet Infectio…

Performance characteristics of five immunoassays for #SARS-CoV-2: a head-to-head benchmark comparison - The Lancet Infectious Diseases All 5 with sens, spec of 98%+. Free download https://t.co/8zXoGU50CU

Comparing 5 immunoassays for #SARSCoV2 head-to-head: https://t.co/2vdSRP0kbW @TheLancetInfDis #coronavirus #COVID19 #diagnostic

Sars-CoV-2 https://t.co/4viALcRHcW

RT @NicStoesser: Great to see this published! A huge effort by a very large number of people and groups; very grateful to all contributors,…

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison https://t.co/5Be8Pfe1Zg

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison https://t.co/uT9VQKHokn

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison - The Lancet Infectious Diseases https://t.co/A7fHhPzDR2

RT @alfonso_casi: Comparación del rendimiento de 5 pruebas (inmunoensayos) para el SARS-CoV-2: se pueden utilizar 4 pruebas serológicas com…

Comparación del rendimiento de 5 pruebas (inmunoensayos) para el SARS-CoV-2: se pueden utilizar 4 pruebas serológicas comerciales ampliamente disponibles y un ELISA escalable de 384 pocillos que logran una sensibilidad y especificidad de al menos el 98%. …

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

RT @BogochIsaac: A helpful study examining various serology tests for #COVID19. They're pretty good. "All assays achieved a sensitivity o…

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

RT @NicStoesser: Great to see this published! A huge effort by a very large number of people and groups; very grateful to all contributors,…

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

RT @TheLancetInfDis: New research Article: Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark compari…

RT @NicStoesser: Great to see this published! A huge effort by a very large number of people and groups; very grateful to all contributors,…

RT @BogochIsaac: A helpful study examining various serology tests for #COVID19. They're pretty good. "All assays achieved a sensitivity o…

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison https://t.co/RpASpxeQcy

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

RT @BogochIsaac: A helpful study examining various serology tests for #COVID19. They're pretty good. "All assays achieved a sensitivity o…

A helpful study examining various serology tests for #COVID19. They're pretty good. "All assays achieved a sensitivity of at least 98% with thresholds optimised to achieve a specificity of at least 98% on samples taken 30 days or more post symptom ons…

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison https://t.co/JBtjjpal75

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

Now that’s a shrewd use of the tire-track trick with geom_jitter()

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

RT @scienceisbeauty: From the 4 current available COVID serology assays, Oxford wins. 👍 ☑️ ...we highlighted the potentially scalable capa…

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

From the 4 current available COVID serology assays, Oxford wins. 👍 ☑️ ...we highlighted the potentially scalable capacity of the Oxford immunoassay, which could enable centralised testing for large-scale projects (eg, national seroprevalence studies)

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

I'm all about interesting stuff this morning: a study showing performance characteristics of 4 commercially available COVID serology assays. This study shows the Oxford assay to have 99+% for both spinning and snouting!

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison https://t.co/mJKPdX2ISC

RT @andrewazman: Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings…

Useful new comparison of the performance of 5 immunoassays in @TheLancetInfDis. Great to see actual quantitative readings from the assays in the main text and a mixture of clinical severity in the SARS-COV-2 positives. https://t.co/MY0nKeKF6E https://…

RT @bealelab: This is a good paper comparing a few widely available serology assays. @ViralHoolahoop and I wrote a short commentary on it (…

This is a good paper comparing a few widely available serology assays. @ViralHoolahoop and I wrote a short commentary on it (before the re-infection cases were documented!). https://t.co/iLyUQzySel

RT @TxID_Edu: #SARSCoV2 Antibody assays "We showed that the Siemens assay & the Oxford immunoassay both achieved sensitivity & specificity…

#SARSCoV2 Antibody assays "We showed that the Siemens assay & the Oxford immunoassay both achieved sensitivity & specificity of at least 98% (with a lower bound of the 95% CI ≥96%) on samples taken at least 20 days post symptom onset w/o optimisa…

RT @LancetMicrobe: New in @TheLancetInfDis>; Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark compar…

Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark comparison Assay sensitivity / specificity: #Abbott 92.7% / 99.9% #DiaSorin 95.0% / 98.7% #Oxford 99.1% / 99.0% #Roche 97.2% / 99.8% #Siemens 98.1% / 99.9% http…

RT @TheLancetInfDis: New research Article: Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark compari…

RT @LancetRespirMed: @TheLancetInfDis Original Research Article from The National SARS-CoV-2 Serology Assay Evaluation Group on performance…

RT @OxfordBRC: Accuracy of Oxford immunoassay highlighted in this head-to-head comparison https://t.co/HhyJZs8l2H @OxfordMedSci @OUHospital…

RT @NicStoesser: Great to see this published! A huge effort by a very large number of people and groups; very grateful to all contributors,…

RT @LancetMicrobe: New in @TheLancetInfDis>; Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark compar…

Noticias de Lancet https://t.co/ldChNn4KKh

RT @LancetMicrobe: New in @TheLancetInfDis>; Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark compar…

RT @LancetRespirMed: Original Research Article from The National SARS-CoV-2 Serology Assay Evaluation Group on performance characteristics…

Original Research Article from The National SARS-CoV-2 Serology Assay Evaluation Group on performance characteristics of five immunoassays for #SARSCoV2 https://t.co/nFO0j4HPJV @TheLancetInfDis https://t.co/kT4Z6sYYBe

New in @TheLancetInfDis>; Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark comparison https://t.co/NAn3gu7WCY #COVID19

RT @TheLancetInfDis: New research Article: Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark compari…

Noticias de Lancet https://t.co/bHbouNKcnM

RT @LancetRespirMed: @TheLancetInfDis Original Research Article from The National SARS-CoV-2 Serology Assay Evaluation Group on performance…

@TheLancetInfDis Original Research Article from The National SARS-CoV-2 Serology Assay Evaluation Group on performance characteristics of five immunoassays for #SARSCoV2 https://t.co/nFO0j4ZqBt (7/7) https://t.co/PfDrgoLOMV

RT @TheLancetInfDis: New research Article: Performance characteristics of five immunoassays for #SARSCoV2: a head-to-head benchmark compari…

RT @NicStoesser: Great to see this published! A huge effort by a very large number of people and groups; very grateful to all contributors,…

Open access

RT @NicStoesser: Great to see this published! A huge effort by a very large number of people and groups; very grateful to all contributors,…

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

About this Attention Score

Mentioned by

Readers on